Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).

Wong G, Hope RL, Howard K, Chapman JR, Castells A, Roger SD, Bourke MJ, Macaskill P, Turner R, Williams G, Lim WH, Lok CE, Diekmann F, Cross NB, Sen S, Allen RDM, Chadban SJ, Pollock CA, Tong A, Teixeira-Pinto A, Yang JYH, Williams N, Au EHK, Kieu A, James L, Craig JC.

J Am Soc Nephrol. 2019 Apr 30. pii: ASN.2018121232. doi: 10.1681/ASN.2018121232. [Epub ahead of print]

PMID:
31040191
2.

Quantity Over Quality: Metrics in Solid Organ Transplantation.

Cross NB, Dittmer I.

Transplantation. 2018 Jul;102(7):1031-1032. doi: 10.1097/TP.0000000000002150. No abstract available.

PMID:
29485509
3.

Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.

Hill P, Cross NB, Barnett AN, Palmer SC, Webster AC.

Cochrane Database Syst Rev. 2017 Jan 11;1:CD004759. doi: 10.1002/14651858.CD004759.pub2. Review.

4.

A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis.

Wright DF, Doogue MP, Barclay ML, Chapman PT, Cross NB, Irvine JH, Stamp LK.

Eur J Clin Pharmacol. 2017 Jan;73(1):71-78. doi: 10.1007/s00228-016-2133-y. Epub 2016 Sep 28.

PMID:
27683090
5.

Renal replacement therapy associated with lithium nephrotoxicity in New Zealand.

Wells JE, Cross NB, Savage RL, Parkin L, Horsburgh S, Richardson AK.

N Z Med J. 2015 Nov 20;128(1425):77-83.

PMID:
26905990
6.

Angiotensin-Converting Enzyme Inhibitors-Beneficial Effects Seen in Many Patient Groups May Not Extend to Kidney Transplant Recipients.

Cross NB, Webster AC.

Transplantation. 2016 Mar;100(3):472-3. doi: 10.1097/TP.0000000000001140. No abstract available.

PMID:
26900806
7.

When evidence doesn't generalise: the case of ACE inhibition.

Webster AC, Cross NB.

Lancet Diabetes Endocrinol. 2016 Apr;4(4):290-2. doi: 10.1016/S2213-8587(15)00415-5. Epub 2015 Oct 23. No abstract available.

PMID:
26608068
8.

Dynamic changes in myeloid derived suppressor cell subsets following renal transplant: A prospective study.

Hock BD, McKenzie JL, Cross NB, Currie MJ.

Transpl Immunol. 2015 Jun;32(3):164-71. doi: 10.1016/j.trim.2015.05.001. Epub 2015 May 9.

PMID:
25968653
9.

Treatment for peritoneal dialysis-associated peritonitis.

Ballinger AE, Palmer SC, Wiggins KJ, Craig JC, Johnson DW, Cross NB, Strippoli GF.

Cochrane Database Syst Rev. 2014 Apr 26;(4):CD005284. doi: 10.1002/14651858.CD005284.pub3. Review.

PMID:
24771351
10.

Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients.

Myint TM, Turner RM, Craig JC, Cross NB, Kable K, Nankivell BJ, Chapman JR, Webster AC, O'Connell P, Dwyer DE, Jeoffreys N, Roger SD, Wong G.

Clin Transplant. 2013 Sep-Oct;27(5):E571-9. doi: 10.1111/ctr.12195. Epub 2013 Aug 17.

PMID:
23952788
11.

A case of pityriasis rubra pilaris associated with membranous nephropathy.

Lin CY, Maurice PD, Cross NB.

Australas J Dermatol. 2013 Feb;54(1):e1-3. doi: 10.1111/j.1440-0960.2011.00807.x. Epub 2011 Sep 2.

PMID:
23373888
12.

Effect of activated human polymorphonuclear leucocytes on T lymphocyte proliferation and viability.

Hock BD, Taylor KG, Cross NB, Kettle AJ, Hampton MB, McKenzie JL.

Immunology. 2012 Nov;137(3):249-58. doi: 10.1111/imm.12004.

13.

The experiences of commercial kidney donors: thematic synthesis of qualitative research.

Tong A, Chapman JR, Wong G, Cross NB, Batabyal P, Craig JC.

Transpl Int. 2012 Nov;25(11):1138-49. doi: 10.1111/j.1432-2277.2012.01534.x. Epub 2012 Jul 25. Review.

14.

Toxicity profile of lithium.

Wells JE, Cross NB, Richardson AK.

Lancet. 2012 Jun 23;379(9834):2338. doi: 10.1016/S0140-6736(12)61012-5. No abstract available.

PMID:
22726509
15.

KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients.

Chadban SJ, Barraclough KA, Campbell SB, Clark CJ, Coates PT, Cohney SJ, Cross NB, Eris JM, Henderson L, Howell MR, Isbel NM, Kanellis J, Kotwal SS, Manley P, Masterson R, Mulley W, Murali K, O'Connell P, Pilmore H, Rogers N, Russ GR, Walker RG, Webster AC, Wiggins KJ, Wong G, Wyburn KR; Kidney Health Australia Caring for Australians with Renal Impairment (KHA-CARI).

Nephrology (Carlton). 2012 Mar;17(3):204-14. doi: 10.1111/j.1440-1797.2011.01559.x. No abstract available.

PMID:
22212251
16.

Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.

Hock BD, Mackenzie KA, Cross NB, Taylor KG, Currie MJ, Robinson BA, Simcock JW, McKenzie JL.

Nephrol Dial Transplant. 2012 Jan;27(1):402-10. doi: 10.1093/ndt/gfr264. Epub 2011 May 26.

PMID:
21617199
17.

How to get the most from the medical literature: searching the medical literature effectively.

Webster AC, Cross NB, Mitchell R, Craig JC.

Nephrology (Carlton). 2010 Feb;15(1):12-9. doi: 10.1111/j.1440-1797.2009.01263.x.

PMID:
20377765
18.

Asking the right question and finding the right answers.

Cross NB, Craig JC, Webster AC.

Nephrology (Carlton). 2010 Feb;15(1):8-11. doi: 10.1111/j.1440-1797.2009.01264.x.

PMID:
20377764
19.

Antihypertensive treatment for kidney transplant recipients.

Cross NB, Webster AC, Masson P, O'Connell PJ, Craig JC.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD003598. doi: 10.1002/14651858.CD003598.pub2. Review.

PMID:
19588343
20.

Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials.

Cross NB, Webster AC, Masson P, O'connell PJ, Craig JC.

Transplantation. 2009 Jul 15;88(1):7-18. doi: 10.1097/TP.0b013e3181a9e960. Review.

PMID:
19584673
21.

Diagnostic accuracy of blood qualitative nucleic acid testing for polyomavirus-associated nephropathy in kidney recipients.

Cross NB, Webster AC, O'Connell PJ, Jeoffreys N, Dwyer DE, Craig JC.

Nephrology (Carlton). 2009 Apr;14(3):350-6.

PMID:
19444968

Supplemental Content

Loading ...
Support Center